CN104398910B - 一种用于治疗滑膜炎的中药制剂 - Google Patents
一种用于治疗滑膜炎的中药制剂 Download PDFInfo
- Publication number
- CN104398910B CN104398910B CN201410667635.7A CN201410667635A CN104398910B CN 104398910 B CN104398910 B CN 104398910B CN 201410667635 A CN201410667635 A CN 201410667635A CN 104398910 B CN104398910 B CN 104398910B
- Authority
- CN
- China
- Prior art keywords
- root
- medicine
- effect
- heat
- clearing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 85
- 201000004595 synovitis Diseases 0.000 title claims abstract description 16
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 229940079593 drug Drugs 0.000 claims abstract description 22
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 8
- 241000219357 Cactaceae Species 0.000 claims abstract description 7
- 241000723346 Cinnamomum camphora Species 0.000 claims abstract description 5
- 244000077995 Coix lacryma jobi Species 0.000 claims abstract description 5
- 244000111489 Gardenia augusta Species 0.000 claims abstract description 5
- 235000018958 Gardenia augusta Nutrition 0.000 claims abstract description 5
- 235000006753 Platycodon grandiflorum Nutrition 0.000 claims abstract description 5
- 240000003582 Platycodon grandiflorus Species 0.000 claims abstract description 5
- 244000197580 Poria cocos Species 0.000 claims abstract description 5
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 5
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 4
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 4
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 claims abstract description 4
- 235000006264 Asimina triloba Nutrition 0.000 claims abstract description 4
- 235000009467 Carica papaya Nutrition 0.000 claims abstract description 4
- 241000112528 Ligusticum striatum Species 0.000 claims abstract description 4
- 241000218378 Magnolia Species 0.000 claims abstract description 4
- 241001522129 Pinellia Species 0.000 claims abstract description 4
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229940116229 borneol Drugs 0.000 claims abstract description 4
- 229930008380 camphor Natural products 0.000 claims abstract description 4
- 229960000846 camphor Drugs 0.000 claims abstract description 4
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 4
- 244000189799 Asimina triloba Species 0.000 claims abstract description 3
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 3
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 3
- 235000017443 Hedysarum boreale Nutrition 0.000 claims abstract description 3
- 235000007858 Hedysarum occidentale Nutrition 0.000 claims abstract description 3
- 244000299790 Rheum rhabarbarum Species 0.000 claims abstract description 3
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims abstract description 3
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 claims abstract description 3
- 229910052602 gypsum Inorganic materials 0.000 claims abstract description 3
- 239000010440 gypsum Substances 0.000 claims abstract description 3
- 210000000582 semen Anatomy 0.000 claims abstract description 3
- 241000213006 Angelica dahurica Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 47
- 239000008280 blood Substances 0.000 abstract description 25
- 210000004369 blood Anatomy 0.000 abstract description 24
- 230000001737 promoting effect Effects 0.000 abstract description 21
- 230000017531 blood circulation Effects 0.000 abstract description 18
- 230000008901 benefit Effects 0.000 abstract description 9
- 230000008595 infiltration Effects 0.000 abstract description 6
- 238000001764 infiltration Methods 0.000 abstract description 6
- 230000001151 other effect Effects 0.000 abstract description 5
- 239000000463 material Substances 0.000 abstract description 4
- 241000411851 herbal medicine Species 0.000 abstract description 3
- 206010067484 Adverse reaction Diseases 0.000 abstract description 2
- 244000061520 Angelica archangelica Species 0.000 abstract description 2
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract description 2
- 230000006838 adverse reaction Effects 0.000 abstract description 2
- 230000001225 therapeutic effect Effects 0.000 abstract description 2
- 230000009471 action Effects 0.000 description 24
- 230000000144 pharmacologic effect Effects 0.000 description 23
- 208000002193 Pain Diseases 0.000 description 20
- 230000036407 pain Effects 0.000 description 18
- 210000004072 lung Anatomy 0.000 description 16
- 210000000952 spleen Anatomy 0.000 description 15
- 230000035508 accumulation Effects 0.000 description 12
- 238000009825 accumulation Methods 0.000 description 12
- 210000000629 knee joint Anatomy 0.000 description 12
- 210000004185 liver Anatomy 0.000 description 12
- 210000002784 stomach Anatomy 0.000 description 12
- 230000003110 anti-inflammatory effect Effects 0.000 description 10
- 230000002401 inhibitory effect Effects 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 10
- 230000008961 swelling Effects 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 8
- 231100000614 poison Toxicity 0.000 description 8
- 206010062717 Increased upper airway secretion Diseases 0.000 description 7
- 239000000284 extract Substances 0.000 description 7
- 239000007789 gas Substances 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 208000026435 phlegm Diseases 0.000 description 7
- 238000012549 training Methods 0.000 description 7
- 230000000202 analgesic effect Effects 0.000 description 6
- 210000003127 knee Anatomy 0.000 description 6
- 208000006820 Arthralgia Diseases 0.000 description 5
- 230000003213 activating effect Effects 0.000 description 5
- 210000000988 bone and bone Anatomy 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- 210000002429 large intestine Anatomy 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 238000005728 strengthening Methods 0.000 description 5
- 241001480043 Arthrodermataceae Species 0.000 description 4
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 4
- 244000061176 Nicotiana tabacum Species 0.000 description 4
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 230000000295 complement effect Effects 0.000 description 4
- 230000006837 decompression Effects 0.000 description 4
- 230000037304 dermatophytes Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 239000010248 fenbid Substances 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 230000007096 poisonous effect Effects 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 230000002335 preservative effect Effects 0.000 description 4
- 230000004224 protection Effects 0.000 description 4
- 230000003637 steroidlike Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 206010065564 Floating patella Diseases 0.000 description 3
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- 206010044565 Tremor Diseases 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- 230000036592 analgesia Effects 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 238000005057 refrigeration Methods 0.000 description 3
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- CLWOXNLVWMXBRD-QGZVFWFLSA-O Magnocurarine Chemical compound C([C@H]1[N+](C)(C)CCC=2C=C(C(=CC=21)O)OC)C1=CC=C(O)C=C1 CLWOXNLVWMXBRD-QGZVFWFLSA-O 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- WWBNBPSEKLOHJU-CEOIDQJPSA-N Sinalbin Natural products S(=O)(=O)(O/N=C(\S[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)/Cc1ccc(O)cc1)O WWBNBPSEKLOHJU-CEOIDQJPSA-N 0.000 description 2
- 241000191940 Staphylococcus Species 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 230000003288 anthiarrhythmic effect Effects 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 239000002221 antipyretic Substances 0.000 description 2
- 210000001772 blood platelet Anatomy 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229940126701 oral medication Drugs 0.000 description 2
- 230000000242 pagocytic effect Effects 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- WWBNBPSEKLOHJU-RFEZBLSLSA-N sinalbin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1S\C(=N/OS(O)(=O)=O)CC1=CC=C(O)C=C1 WWBNBPSEKLOHJU-RFEZBLSLSA-N 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 210000001258 synovial membrane Anatomy 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 206010001497 Agitation Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- 241001260012 Bursa Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 240000006432 Carica papaya Species 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- 240000008918 Chaenomeles cathayensis Species 0.000 description 1
- 235000009810 Chaenomeles cathayensis Nutrition 0.000 description 1
- 241000186227 Corynebacterium diphtheriae Species 0.000 description 1
- 241000588921 Enterobacteriaceae Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- IBFYXTRXDNAPMM-FZEIBHLUSA-N Geniposide Natural products COC(=O)C1=CO[C@@H](O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O)[C@H]2[C@@H]1CC=C2CO IBFYXTRXDNAPMM-FZEIBHLUSA-N 0.000 description 1
- -1 Geniposide Glucoside Chemical class 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010018852 Haematoma Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 229910052764 Mendelevium Inorganic materials 0.000 description 1
- 241000192041 Micrococcus Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000005214 Poroma Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 240000004980 Rheum officinale Species 0.000 description 1
- 235000008081 Rheum officinale Nutrition 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 208000026137 Soft tissue injury Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 208000009729 Ventricular Premature Complexes Diseases 0.000 description 1
- 206010047281 Ventricular arrhythmia Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- ZOJBYZNEUISWFT-UHFFFAOYSA-N allyl isothiocyanate Chemical compound C=CCN=C=S ZOJBYZNEUISWFT-UHFFFAOYSA-N 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000001949 anaesthesia Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000879 anti-atherosclerotic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000003474 anti-emetic effect Effects 0.000 description 1
- 230000001986 anti-endotoxic effect Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000001857 anti-mycotic effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000002467 anti-pepsin effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000003260 anti-sepsis Effects 0.000 description 1
- 230000001663 anti-spastic effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 239000002111 antiemetic agent Substances 0.000 description 1
- 239000002543 antimycotic Substances 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- VGLLGNISLBPZNL-RBUKDIBWSA-N arborescoside Natural products O=C(OC)C=1[C@@H]2C([C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)OC=1)=C(CO)CC2 VGLLGNISLBPZNL-RBUKDIBWSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 150000007980 azole derivatives Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000005961 cardioprotection Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000009194 climbing Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 201000001013 eccrine acrospiroma Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001965 increasing effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 210000000281 joint capsule Anatomy 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 229940040145 liniment Drugs 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- MQVSLOYRCXQRPM-UHFFFAOYSA-N mendelevium atom Chemical compound [Md] MQVSLOYRCXQRPM-UHFFFAOYSA-N 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000008164 mustard oil Substances 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 150000002926 oxygen Chemical class 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 208000011906 peptic ulcer disease Diseases 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 238000005220 pharmaceutical analysis Methods 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- ADRDEXBBJTUCND-UHFFFAOYSA-N pyrrolizidine Chemical compound C1CCN2CCCC21 ADRDEXBBJTUCND-UHFFFAOYSA-N 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229940007046 shigella dysenteriae Drugs 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000003699 striated muscle Anatomy 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A61K31/125—Camphor; Nuclear substituted derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/33—Cactaceae (Cactus family), e.g. pricklypear or Cereus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/732—Chaenomeles, e.g. flowering quince
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
一种用于治疗滑膜炎的中药制剂,其特征在于,由以下重量的原料药制成的药剂:白芷14‑16g、川芎14‑16g、茯苓14‑16g、当归14‑16g、赤芍14‑16g、半夏14‑16g、陈皮14‑16g、枳壳14‑16g、甘遂14‑16g、栀子14‑16g、桔梗14‑16g、厚朴14‑16g、木瓜14‑16g、大白14‑16g、樟脑2‑4g、石膏90‑110g、冰片4‑6g、炙甘草14‑16g、薏苡仁25‑35g、白芥子15‑25g、生大黄14‑16g、仙人掌200‑300g、金银花200‑300g。本发明采用中草药配方,材料易得,制备方法简单,服用治疗效果好,价格低,具有祛邪通络、温中除湿、活血化瘀、清热、渗水等功效,见效快,疗效可靠,随制随用无明显不良反应和副作用。
Description
技术领域
本发明涉及中草药技术领域,具体涉及一种用于治疗滑膜炎的中药制剂。
背景技术
滑膜炎(热型)是一种多发性疾病,其发病部位主要在膝关节。膝关节是人体滑膜最多,关节面最大和结构最复杂的关节,由于膝关节滑膜广泛,并位于肢体较浅部位,故遭受损伤和感染的机会较多,膝关节滑膜炎主要是因膝关节扭伤和多种关节内损伤,而造成的一组综合症。膝关节明显肿胀、发热,活动受限。检查发现膝关节屈伸活动受限,下蹲困难并伴有疼痛,关节周围可有局限性压疼点,髌上囊有囊性感,浮髌试验阳性。慢性损伤性滑膜,可能无明显外伤史,主要表现膝关节发软及活动受限,肿胀持续不退,下蹲受限。活动增多时加重,休息后减轻。久病者,可钔到膝关节囊肥厚感。从中医角度看归于痹证,痹证是由于风、寒、湿、热、痰、瘀等邪气闭阻经络,影响气血运行,导致肢体、筋骨、关节、肌肉等处发生疼痛、重着、酸楚麻木,或关节屈伸不利、僵硬、重大、变形等症状的一种疾病。《诸病源候论》又称为“历节风”;王肯堂《证治准绳》对膝关节肿大者称为“鹤膝风”。
发明内容
本发明的目的在于提供一种使用安全可靠,治愈率高的用于治疗滑膜炎的中药制剂。
本发明所要解决的技术问题采用以下技术方案来实现:
一种用于治疗滑膜炎的中药制剂,由以下重量的原料药制成的药剂:
各原料药的优选重量为:
本发明所用到的原料药可从普通中药店购买得到,其规格符合国家中药材标准即可。
剂型:清热消积散。
制作方法及用法:
鲜仙人掌250g洗净,去皮刺捣碎为泥鲜用;按上述剂量清热消积散各药打碎为末,金银花250g煎水适量;将上述药物调成药泥,敷于患处,外用保鲜膜包裹,留置24小时。
辅助疗法:
1)针刀松解、减压治疗;
2)西药辅助治疗:①非甾体类药物,如:芬必得、英太青;②活血化瘀药物,如:活血止痛胶囊;
3)适当功能锻炼;
4)避免负重、忌烟酒。
功用:祛邪通络、温中除湿、活血化瘀、清热、渗水。
主治:滑膜炎(热型)。
药物分析:
白芷:
【药性】辛,温。归肺、胃、大肠经。
【功效】解表散寒,祛风止痛,通鼻窍,燥湿止带,消肿排脓。
【药理作用】有解热、抗炎、镇痛、解痉、抗癌作用。
川芎:
【药性】辛,温。归肝、胆、心包经。
【功效】活血行气,祛风止痛。
【药理作用】川芎可扩张血管,改善微循环;能够降低血小板表面活性,抑制血小板凝集,预防血栓的形成。有镇静的作用,并有明显而持久的降压作用;可加速骨折局部血肿的吸收,促进骨痂的形成;能抑制多种杆菌。
茯苓:
【药性】甘、淡、平。归心、脾、肾经。
【功效】解毒、除湿,通利关节。
【药理作用】茯苓醇提取物、乙醚提取物,分别具有利尿、镇静、抗肿瘤、降血糖、增加心肌收缩力的作用。茯苓多糖有增强免疫功能的作用。茯苓有护肝作用,能降低胃液分泌,对胃溃疡有抑制作用。
当归:
【药性】甘、辛、温。归肝、心、脾经。
【功效】补血调经,活血止痛,润肠通便。
【药理作用】当归有保护心脏、抗心律失常、抗动脉粥样硬化心肌梗死,抑制平滑肌,抗血小板聚集,抗炎作用,增强机体免疫功能,脑缺血损伤的保护,抗肿瘤,使细胞增殖,保护肝脏和肾脏等作用现代药理学研究进一步证明了当归活血化瘀、补血止痛等作用,同时还发现,当归有抗炎、清除氧自由基、保肝利胆、保护肾脏、增强免疫功能等作用。
赤药:
【药性】苦,微寒。归肝经。
【功效】清热凉血,散瘀止痛。
【药理作用】赤芍水提液、赤芍苷、赤芍成分及其衍生物有抑制血小板聚集作用;其水煎剂能延长体外血栓形成时间,减轻血栓干重。所含芍药苷有镇静、抗炎止痛作用。芍药流浸膏、芍药苷有抗惊厥作用。赤芍、芍药苷有解痉作用;赤芍对肝细胞DNA的合成有明显的增强作用,对多种病原微生物有较强的抑制作用。
半夏:
【药性】辛、温。有毒。归脾、胃、肺经。
【功效】燥湿化痰,降逆止呕,消痞散结;外用消肿止痛。
【药理作用】可抑制呕吐中枢而止吐,各种炮制品对实验动物均有明显的止咳作用。半夏的稀醇和水浸液或其多糖组分、生物碱具有较广泛的抗肿瘤作用。水浸剂对实验性室性心律失常和室性期前收缩有明显的对抗作用。
陈皮:
【药性】辛、温、苦。归脾、肺经。
【功效】理气健脾,燥湿化痰。
【药理作用】陈皮小剂量可增强心脏收缩力,使心输出量增加,冠脉扩张,使冠脉流量增加,大剂量时可抑制心脏;陈皮水溶性总生物碱具有升高血压作用;提取物有清除氧自由基和抗脂质过氧化作用;鲜橘皮煎剂有扩张气管的作用。
枳壳:
【药性】苦、辛、酸、温。归脾、胃、大肠经。
【功效】破气消积,化痰除痞。
【药理作用】较强的扩张气管和支气管的作用。有抗血栓、抗癌、抗炎、抗真菌、利尿、抗变态作用。
甘遂:
【药性】苦、寒;有毒。归肺、肾、大肠经。
【功效】泻水逐饮,消肿散结。
【药理作用】外用能消肿散结,治疗痈肿毒。
栀子:
【药性】苦,寒。归心、肺、三焦经。
【功效】泻火除烦,清热利湿,凉血解读。
【药理作用】栀子对金黄色葡萄球菌、脑膜炎双球菌、卡他球菌等有抑制作用,水浸液在体外对多种皮肤真菌有抑制作用。栀子乙醇提取物,水提取物,乙酸乙酯部分和京尼平甙有一定的抗炎和治疗软组织损伤的作用。其提取物制成油膏,可加速软组织的愈合。
桔梗:
【药性】苦、辛、平。归肺经。
【功效】宣肺,祛痰,利咽,排脓。
【药理作用】桔梗有镇咳作用,有增强抗炎和免疫作用;水提取物能增强巨噬细胞的吞噬功能,增强中性细胞的杀菌力。桔梗粗皂苷有镇静、镇痛、解热作用。
厚朴:
【药性】苦、辛、温。归脾、胃、肺、大肠经。
【功效】燥湿消痰,下气除满。
【药理作用】厚朴对肺炎球菌、白喉杆菌、溶血性链球菌、枯草杆菌、志贺氏及施氏痢疾杆菌、金黄色葡萄球菌及若干皮肤真菌均有抑制作用。厚朴碱能松弛横纹肌。
木瓜:
【药性】酸、温。归肝、脾经。
【功效】舒筋活络,和胃化湿。
【药理作用】木瓜汁和木瓜煎剂对肠道菌和葡萄球菌有明显的抑菌作用其提取物对巨噬细胞吞噬功能有抑制作用。
大白:
【药性】味甘;性平;有毒。
【功效】清热解毒。
【药理作用】在体外、体内本类中某些生物碱及其代谢产物(吡咯衍生物),皆属强的烃化剂,双稠吡咯定对肝、肺、血管内皮细胞的毒性及其他作用,皆与其烃化作用有关。
生石膏:
【药性】甘、辛,大寒。归肺、胃经。
【功效】生用:清热泻火,除烦止渴;煅用:敛疮生肌,收湿,止血。
【药理作用】可抑制体温调节中枢、减轻骨骼肌的兴奋性、减少血管通透性,有解热、镇痉、消炎、抗病毒等功效。
樟脑:
【药性】辛、热。有毒。归心、脾经。
【功效】除湿杀虫,温散止痛,开窍辟秽。
【药理作用】樟脑涂擦皮肤有温和的刺激和防腐作用,并有局部麻醉作用,临床樟脑擦剂有止痒和镇痛作用。
冰片:
【药性】辛、苦,微寒。归心、脾,肺经。
【功效】开窍醒神,清热止痛。
【药理作用】冰片局部应用对感觉神经有轻微刺激,有一定的止痛及温和防腐作用。轻度浓度(0.5%)对葡萄球菌、链球菌、肺炎双球菌、大肠杆菌及部分致病性皮肤真菌等有抑制作用。
生大黄:
【药性】苦,寒。归脾、胃、大肠、肝、心经。
【功效】泻下攻积,清热泻火,止血,解毒,活血祛瘀。
【药理作用】大黄具有很强的抗感染作用、抗衰老抗氧化作用、能够调节免疫、抗炎、解热作用、抗病原微生物作用、泻热通肠、凉血解毒、逐瘀通经等功效。
炙甘草:
【药性】甘,平。归心、肺、脾、胃经。
【功效】补脾益气,清热解毒,缓急止痛,调和诸药。
【药理作用】甘草祛痰镇咳,抗心律失常,降脂、降胆固醇,抗血小板聚集,抗病原微生物;抗消化性溃疡,抗肠痉挛;具有保肝、镇痛、解热、镇静、抗过敏作用。
白芥子:
【药性】辛、温。归肺、胃经。
【功效】温肺化痰,利气散结,活络止痛。
【药理作用】白芥子苷水解后的产物白芥油有较强的刺激作用,可致皮肤充血、发泡。水浸剂对皮肤真菌有抑制作用。
薏苡仁:
【药性】甘、淡、凉。归脾、胃、肠经。
【功效】利水渗湿,健脾,除痹,清热排毒。
【药理作用】薏苡仁醇及丙酮提取物对癌细胞有明显抑制作用。薏苡仁内酯对小肠有抑制作用。其脂肪油能使血清钙、血糖量降低,并有解毒、镇静、镇痛作用。
金银花:
【药性】甘,寒。归肺、心、胃经。
【功效】清热解毒,疏散风热。
【药理作用】金银花有抗病原微生物作用;抗炎和解热作用;加强防御机能作用;中枢兴奋作用;降血脂作用;抗内毒素作用。
仙人掌:
【药性】甘,性平。归肺、胃经。
【功效】行气活血,清热解毒。
【药理作用】消肿止痛,行气活血,祛湿退热,生肌。
为了验证临床疗效,本组方在界首市风湿病研究所所进行试用,通过随机选取其中500例病人;并进行长期的跟踪回访,发现用药数次后患者症状明显缓解。
治疗方法
按照本发明服用方法。
4)疗效判定:采用三级标准;
①治愈:临床症状基本消失,心电图基本恢复正常。
②好转:临床症状明显减轻,心电图改变明显改善。
③无效:临床症状无明显改善,心电图改善无恢复。
具体临床治疗结果参见表1。
表1
例数 | 痊愈 | 有效 | 无效 | 有效率(%) |
500 | 330 | 160 | 10 | 98 |
诊疗结果:有效率98%,总结本方治疗热型滑膜炎,疗效确切,并能改变病理症状。
本发明的有益效果是:本发明采用中草药配方,材料易得,制备方法简单,服用治疗效果好,价格低,具有祛邪通络、温中除湿、活血化瘀、清热、渗水等功效,见效快,疗效可靠,随制随用无明显不良反应和副作用。
具体实施方式
为了使本发明实现的技术手段、创作特征、达成目的与功效易于明白了解,下面结合具体实施例,进一步阐述本发明。
实施例1
一种用于治疗滑膜炎的中药制剂,由以下重量的原料药制成的药剂:
本发明所用到的原料药可从普通中药店购买得到,其规格符合国家中药材标准即可。
剂型:清热消积散。
制作方法及用法:
鲜仙人掌250g洗净,去皮刺捣碎为泥鲜用;按上述剂量清热消积散各药打碎为末,金银花250g煎水适量;将上述药物调成药泥,敷于患处,外用保鲜膜包裹,留置24小时。
辅助疗法:
1)针刀松解、减压治疗;
2)西药辅助治疗:①非甾体类药物,如:芬必得、英太青;②活血化瘀药物,如:活血止痛胶囊;
3)适当功能锻炼;
4)避免负重、忌烟酒。
功用:祛邪通络、温中除湿、活血化瘀、清热、渗水。
主治:滑膜炎(热型)。
实施例2
一种用于治疗滑膜炎的中药制剂,由以下重量的原料药制成的药剂:
本发明所用到的原料药可从普通中药店购买得到,其规格符合国家中药材标准即可。
剂型:清热消积散。
制作方法及用法:
鲜仙人掌250g洗净,去皮刺捣碎为泥鲜用;按上述剂量清热消积散各药打碎为末,金银花250g煎水适量;将上述药物调成药泥,敷于患处,外用保鲜膜包裹,留置24小时。
辅助疗法:
1)针刀松解、减压治疗;
2)西药辅助治疗:①非甾体类药物,如:芬必得、英太青;②活血化瘀药物,如:活血止痛胶囊;
3)适当功能锻炼;
4)避免负重、忌烟酒。
功用:祛邪通络、温中除湿、活血化瘀、清热、渗水。
主治:滑膜炎(热型)。
实施例3
一种用于治疗滑膜炎的中药制剂,由以下重量的原料药制成的药剂:
本发明所用到的原料药可从普通中药店购买得到,其规格符合国家中药材标准即可。
剂型:清热消积散。
制作方法及用法:
鲜仙人掌250g洗净,去皮刺捣碎为泥鲜用;按上述剂量清热消积散各药打碎为末,金银花250g煎水适量;将上述药物调成药泥,敷于患处,外用保鲜膜包裹,留置24小时。
辅助疗法:
1)针刀松解、减压治疗;
2)西药辅助治疗:①非甾体类药物,如:芬必得、英太青;②活血化瘀药物,如:活血止痛胶囊;
3)适当功能锻炼;
4)避免负重、忌烟酒。
功用:祛邪通络、温中除湿、活血化瘀、清热、渗水。
主治:滑膜炎(热型)。
病案1:
曹某,男,28岁,务农。因“左膝关节疼痛、肿胀半年余,加重10天”就诊。患者半年前在活动后出现左膝关节疼痛不适,逐渐加重,隧到当地诊所就诊,给予口服药物治疗,具体用药不祥;症状缓解,半年来左膝关节疼痛偶有发作;10天前,爬山后出现左膝关节疼痛加重,并逐渐加重,并伴有关节肿胀、蹲起困难,行走疼痛加重;左膝关节DR片示:左膝关节滑膜炎;随来我院就诊门诊诊断:“左膝关节滑膜炎”收住院。
住院期间予清热消积散外敷及膝关节局部针刀松解术,配合中西药活血化瘀、补肝肾、强筋骨、通络止痛对症处理。适当功能锻炼。
回访结果:患者半月后来院复查正常;半年后回访未复发。
病案2:
杨秀兰,女,75岁,农民。因“左膝部疼痛10年余,加重1日”就诊。患者因长期从事农活等劳动,10年前出现左膝部疼痛不适,初始疼痛不明显,后逐渐加重,口服止痛药后缓解,痛甚时在当地诊所输液、膏药外敷、针灸等处理。患者1日前突感左膝部发热、疼痛难忍,不能下床行走,夜不能寐,于今日来我院门诊就医,查:左膝关节活动度明显受限,髌周压痛(++)、局部皮肤发热,浮髌试验(++)。患者要求住院治疗,门诊拟以“左膝关节滑膜炎”收治入院。
住院期间予外清热消积散外敷,并予中西药活血化瘀、利水消肿、补肝肾、强筋骨、通络止痛、增强体质对症处理,并配合卧床休息,适当功能锻炼。
回访结果:10天后患者左膝关节肿胀、发热消失,活动受限较前好转。3月后回访患者关节肿胀、发热未出现。
病案3:
张某某,女,68岁,务农。因“右膝部肿胀2年,加重1日”就诊。患者2年半前行“右股骨头置换术”,半年后发现右膝部略有肿胀,程度不甚,未做特殊治疗。2年间患者右膝部肿胀一直存在,疼痛不甚,口服药物、输液等处理一直未见缓解,因未影响患者正常运动及生活,遂未予重视。1日前患者突感右膝部肿胀加剧,疼痛明显,不能站立及行走,夜不能寐,患者及其家属担心病情进一步加重,于今晨来我院就医,并要求住院治疗,查:患者右膝关节红肿热痛,屈伸活动受限,浮髌试验(++)。门诊拟以“右膝滑膜炎”收治入院。
患者住院期间予清热消积散外敷,予中西药抗炎补液、活血化瘀、利水消肿、补肝肾、强筋骨、通络止痛、增强体质对症处理,并配合卧床休息,适当功能锻炼。
回访结果:半月后患者症状明显缓解,红肿热痛不明显,活动受限较前明显好转。3月后回访患者活动受限稍有,无红肿热痛。
病例4
郭影,女,46岁,农民。因“右膝部疼痛10年余,加重1年”就诊。患者因长期从事负重劳动,10年前出现左膝部疼痛,活动不利,程度不甚,未影响正常生活及劳动,遂未予重视。10年间患者稍有劳累即感右膝部疼痛不适,休息及口服止痛药有所减轻,但持续时间不长。1年前患者受累后右膝部疼痛加重,稍有劳累即感疼痛难忍,一直口服止痛药维持,严重影响患者的正常生活,遂于今日在家人陪同下来我院就医。门诊查:右膝关节活动受限,关节肿胀畸形,无明显发热,浮髌试验(+)、研磨试验(+);患者要求住院治疗,门诊拟以“右膝关节滑膜炎”收住院。
住院期间予清热消积散外敷,配合中西药活血化瘀、补肝肾、强筋骨、通络止痛对症处理,期间配合适当功能锻炼。
回访结果:20天后来院复查,患者自诉症状较前明显好转;查体:右膝关节活动度可,关节畸形,肿胀不明显,浮髌试验(-),研磨试验(-)。3月后回访患者诉正常无复发。
以上显示和描述了本发明的基本原理和主要特征和本发明的优点。本行业的技术人员应该了解,本发明不受上述实施例的限制,上述实施例和说明书中描述的只是说明本发明的原理,在不脱离本发明精神和范围的前提下,本发明还会有各种变化和改进,这些变化和改进都落入要求保护的本发明范围内。本发明要求保护范围由所附的权利要求书及其等效物界定。
Claims (1)
1.一种用于治疗滑膜炎的中药制剂,其特征在于,由以下重量的原料药制成的药剂:白芷15g、川芎15g、茯苓15g、当归15g、赤芍15g、半夏15g、陈皮15g、枳壳15g、甘遂15g、栀子15g、桔梗15g、厚朴15g、木瓜15g、大白15g、樟脑3g、石膏100g、冰片5g、炙甘草15g、薏苡仁30g、白芥子20g、生大黄15g、仙人掌250g、金银花250g。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410667635.7A CN104398910B (zh) | 2014-11-20 | 2014-11-20 | 一种用于治疗滑膜炎的中药制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410667635.7A CN104398910B (zh) | 2014-11-20 | 2014-11-20 | 一种用于治疗滑膜炎的中药制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104398910A CN104398910A (zh) | 2015-03-11 |
CN104398910B true CN104398910B (zh) | 2018-01-12 |
Family
ID=52636619
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410667635.7A Active CN104398910B (zh) | 2014-11-20 | 2014-11-20 | 一种用于治疗滑膜炎的中药制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104398910B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106963901A (zh) * | 2017-05-23 | 2017-07-21 | 张颖 | 一种治疗滑膜炎的新型药物制剂及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1634312A (zh) * | 2004-09-23 | 2005-07-06 | 杨琰 | 治疗骨结核、骨髓炎、滑膜炎、脉管炎的药物 |
CN101284076A (zh) * | 2008-05-19 | 2008-10-15 | 屠瑞丽 | 舒筋活血丸新制法及质量控制方法 |
-
2014
- 2014-11-20 CN CN201410667635.7A patent/CN104398910B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1634312A (zh) * | 2004-09-23 | 2005-07-06 | 杨琰 | 治疗骨结核、骨髓炎、滑膜炎、脉管炎的药物 |
CN101284076A (zh) * | 2008-05-19 | 2008-10-15 | 屠瑞丽 | 舒筋活血丸新制法及质量控制方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104398910A (zh) | 2015-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103893727A (zh) | 一种止痛活血舒筋贴膏及其制备方法 | |
CN102228485B (zh) | 用于烧伤康复的组合物及其制备方法 | |
CN101791378B (zh) | 一种用于伤口止血、抗炎、生肌的中药制剂 | |
CN102847021B (zh) | 一种治疗溃疡性结肠炎的灌肠剂及其制备方法 | |
CN104258278A (zh) | 骨伤灵喷雾剂 | |
CN104258304A (zh) | 一种通经祛风活络消痛的药酒 | |
CN104398910B (zh) | 一种用于治疗滑膜炎的中药制剂 | |
CN102784343B (zh) | 一种治疗牛皮癣的外用中药制剂 | |
CN104491642A (zh) | 一种防治痛风的足浴粉剂 | |
CN105596771A (zh) | 一种治疗隐匿性肾小球肾炎的药剂的制备方法 | |
CN105412692A (zh) | 一种用于治疗鹤膝风的中药制剂 | |
CN1315516C (zh) | 一种治疗风湿病的药物 | |
CN105770796A (zh) | 一种治疗软组织损伤药酒搽剂 | |
CN104840838A (zh) | 一种治疗骨科扭挫伤的中药膏剂 | |
CN110478416A (zh) | 治疗风湿性类风湿性关节炎的组合物及其制备方法和应用 | |
CN110038101A (zh) | 一种中药祛痛止痒外用制剂及其制备方法 | |
CN103610914B (zh) | 一种治疗风湿性关节炎的内服中药酒 | |
CN105362944A (zh) | 一种治疗骨科扭挫伤的中药膏剂 | |
CN102861195B (zh) | 一种治疗风湿疼痛的药物组合物 | |
CN105497817A (zh) | 一种用于踝关节外伤后肿胀的中药制剂及其制备方法 | |
CN107510765A (zh) | 一种治疗痰瘀痹络型风湿痹症的中药组合物及其制备方法 | |
CN104257967A (zh) | 一种治疗运动损伤的中药 | |
CN105012483A (zh) | 一种治疗头部脂溢性皮炎的中药组合物及制备方法 | |
CN104689254A (zh) | 一种治疗银屑病的中药组合物 | |
CN104971209A (zh) | 治疗足癣的外用剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |